Your Source for Venture Capital and Private Equity Financings

Artio Medical Inks $28M Series A2 & A3

2022-06-16
PRAIRIE VILLAGE, KS, Artio Medical today announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing.
Artio Medical, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, today announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million. Funds will be used to support US commercialization efforts for the recently cleared Solus Gold™ Embolization Device and to accelerate the development of Artio's broad portfolio of products, including expanding the Company's engineering and manufacturing capabilities.

Artio Medical is a medical device company committed to developing innovative products for the treatment of peripheral vascular, neurovascular, and cardiovascular diseases.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors


Featured Reading